Cleo Diagnostics (ASX:COV) Shares Buyback Ratio % : 0.00 (As of May. 23, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Cleo Diagnostics's current shares buyback ratio was 0.00%.

Cleo Diagnostics Shares Buyback Ratio % Historical Data

The historical data trend for Cleo Diagnostics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Shares Buyback Ratio % Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Shares Buyback Ratio %

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Shares Buyback Ratio %	-	64.98	-185.56

Cleo Diagnostics Shares Buyback Ratio % Calculation

Cleo Diagnostics's Shares Buyback Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: . 20 )	-	Shares Outstanding (EOP) (A: Jun. 2023 ))	/	Shares Outstanding (EOP) (A: . 20 )
	=	(	-	45)	/
	=	N/A%

Cleo Diagnostics's Shares Buyback Ratio for the quarter that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	(45	-	128.5)	/	45
	=	-185.56%

Cleo Diagnostics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines